These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15177773)

  • 41. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cytotoxic antibodies in multiple sclerosis].
    Rumbach L; Tongio MM; Mayer S; Marescaux C; Warter JM; Collard M
    Pathol Biol (Paris); 1987 Mar; 35(3):307-12. PubMed ID: 3295696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.
    Beyer NH; Milthers J; Bonde Lauridsen AM; Houen G; Lautrup Frederiksen J
    Scand J Clin Lab Invest; 2007; 67(7):696-706. PubMed ID: 17852796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis.
    Ateş A; Kinikli G; Turgay M; Duman M
    Clin Rheumatol; 2004 Oct; 23(5):421-5. PubMed ID: 15459814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone and insulin growth factor-I levels in plasma and cerebrospinal fluid of patients with multiple sclerosis.
    Poljakovic Z; Zurak N; Brinar V; Korsic M; Basic S; Hajnsek S
    Clin Neurol Neurosurg; 2006 Mar; 108(3):255-8. PubMed ID: 16386830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Bartosik-Psujek H; Stelmasiak Z
    J Neural Transm (Vienna); 2005 Jun; 112(6):797-803. PubMed ID: 15480850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
    Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma.
    Ma Y; Ye F; Lv W; Cheng Q; Chen H; Xie X
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):204-11. PubMed ID: 17826886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
    Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
    J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
    Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
    Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis.
    Kawajiri M; Mogi M; Osoegawa M; Matsuoka T; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI
    Mult Scler; 2008 May; 14(4):557-60. PubMed ID: 18562510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galactosylceramide: a reliable serum index of demyelination in multiple sclerosis.
    Lubetzki C; Thuillier Y; Galli A; Lyon-Caen O; Lhermitte F; Zalc B
    Ann Neurol; 1989 Sep; 26(3):407-9. PubMed ID: 2802541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
    Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
    Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
    Jabłońska E; Kiersnowska-Rogowska B; Rogowski F; Parfieńczyk A; Puzewska W; Bukin M
    Rocz Akad Med Bialymst; 2005; 50():204-7. PubMed ID: 16358967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Inoue A; Koh CS; Sakai T; Yamazaki M; Yanagisawa N; Usuku K; Osame M
    J Neuroimmunol; 1997 May; 75(1-2):141-6. PubMed ID: 9143247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
    Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
    J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy.
    Dujmovic I; Mangano K; Pekmezovic T; Quattrocchi C; Mesaros S; Stojsavljevic N; Nicoletti F; Drulovic J
    J Neuroimmunol; 2009 Feb; 207(1-2):101-6. PubMed ID: 19162335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M; Ohta K
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.